Gland Pharma names Ankit Gupta as Vice-President (Strategy and Investments)
Telangana: Gland Pharma has announced that Ankit Gupta has been appointed as Vice-President (Strategy & Investments), a Senior Management Personnel of the Company, effective 04th September, 2023.Ankit has ~15 years of experience in the pharmaceutical and biotechnology industry. He is a finance professional and a business leader who has worked on corporate strategy and...
Telangana: Gland Pharma has announced that Ankit Gupta has been appointed as Vice-President (Strategy & Investments), a Senior Management Personnel of the Company, effective 04th September, 2023.
Ankit has ~15 years of experience in the pharmaceutical and biotechnology industry. He is a finance professional and a business leader who has worked on corporate strategy and growth initiatives for diverse businesses. He has a proven track record of executing successful organic and inorganic growth initiatives, optimizing assets, managing risks, and transforming businesses in an evolving environment. He will spearhead strategic growth initiatives and strategic investments at Gland. Before joining Gland, Ankit was the Vice President and Head of Corporate Development and Strategy for Strides Pharma Science Limited. Before Strides, Ankit was part of the consulting leadership team for Christensen (now EY Transaction Advisory), a capital market firm based in Mumbai. He also had a stint with other pharmaceutical companies in API and formulations.
Ankit has an MBA in Finance (Gold Medalist) and other certifications in corporate finance, private equity, valuations, business leadership, and strategy.
Read also: Gland Pharma to infuse Rs 400 crore to expand Genome Valley facility
Gland Pharma, a generic injectable-focused pharmaceutical company, was established in 1978 in Hyderabad. The company is present in sterile injectables, oncology and ophthalmic segments, and focuses on complex injectables including NCE-1s, First-to-File products and 505(b)(2) filings.
Read also: USFDA concludes inspection at Gland Pharma Visakhapatnam facility with zero 483 observations
Its products are currently delivered via liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops; and efforts are underway to augment additional manufacturing capabilities in complex injectables such as peptides, long-acting injectables, suspensions and hormonal products. Gland is also in the process of including new delivery systems such as pens and cartridges into our product portfolio.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd